澳大利亚Cellestis
Cellestis是一家涉及医疗诊断和科学研究的公司，并是QuantiFERON技术的开发商兼产品营销商。QuantiFERON专利技术是一种利用全血技术，就介导免疫淋巴细胞对T细胞的反应进行检测。
  
Cellestis Limited is an Australian public company with operations in the United States (Cellestis Inc. located in Valencia, CA), Europe (Cellestis GmbH located in Darmstadt, Germany) and Australia (Cellestis International located in Melbourne, VIC). Cellestis Ltd is listed on the Australian Stock Exchange under the code CST.

Cellestis develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune (CMI) responses of T cell lymphocytes using whole blood samples. This unique technology provides accuracy and sensitivity, along with major savings in operator time, labour and reagents compared to other means of measuring CMI.

The QuantiFERON technology, with its simple In-Tube blood incubation step, is well suited to diagnostic pathology laboratory use in a number of infectious diseases and medical conditions. The method is also suitable for clinical research, clinical testing in vaccine development and any indication where the monitoring of CMI responses is required. Cellestis currently manufactures and markets four QuantiFERON product lines;

QuantiFERON-TB Gold In-Tube
QuantiFERON-CMV

Other products using the QuantiFERON technology are under development.

Quality Policy

Cellestis Limited is an innovative Australian biotechnology company committed to building a profitable and growing business by developing and distributing human diagnostic products for the detection of cellular immune response.

We understand the importance of quality and are committed to complying with the requirements of a Quality Management System. We will strive to maintain the effectiveness of the Quality Management System in all areas of our business. We operate according to a Quality Management System, which complies with the requirements set out by the International Standard Organisation in the current edition of ISO 13485 and by regulatory agencies.

We are dedicated to supplying the highest quality product with complete customer satisfaction and service. Cellestis believes quality people are essential to the business operation and supports a culture that embraces teamwork, innovation, technical excellence and professional integrity.

International Resources

Languages spoken at Cellestis include English, Spanish, German, French, Italian, Dutch, Polish, Greek, Norwegian, Croatian, Afrikaans, Arabic, Hindi, Swahili, Mandarin and Japanese.